Concepedia

Maria Gabriella Brasca

MG

Statistics

Publications

31

Citations

1.5K

H-Index

22

Active since

1988

Affiliations

Nerviano Medical Sciences(Current)

Imperial College London

European Institute of Oncology

Novartis (Switzerland)

University of Rome Tor Vergata

Maria Gabriella Brasca is an author at Nerviano Medical Sciences specializing in drug discovery, medicinal chemistry, and pharmacology.

Publications per year

1988–2015

31

Publications

31

3-Aminopyrazole Inhibitors of CDK2/Cyclin A as Antitumor Agents. 1. Lead Finding

Paolo Pevarello, Maria Gabriella Brasca, Raffaella Amici et al. · Journal of Medicinal Chemistry · 2004 · 161 citations · Full text

, , +16

Identification of <i>N</i>,1,4,4-Tetramethyl-8-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-4,5-dihydro-1<i>H</i>-pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide (PHA-848125), a Potent, Orally Available Cyclin Dependent Kinase Inhibitor

Maria Gabriella Brasca, Nadia Amboldi, Dario Ballinari et al. · Journal of Medicinal Chemistry · 2009 · 128 citations · Full text

, , +17

3-Aminopyrazole Inhibitors of CDK2/Cyclin A as Antitumor Agents. 2. Lead Optimization

Paolo Pevarello, Maria Gabriella Brasca, Paolo Orsini et al. · Journal of Medicinal Chemistry · 2005 · 109 citations · Full text

, , +17

NMS-P937, a 4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline derivative as potent and selective Polo-like kinase 1 inhibitor

Italo Beria, R Bossi, Maria Gabriella Brasca et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 104 citations · Full text

, , +7

A highly convergent total synthesis of the spiroacetal macrolide (+)-milbemycinβ1

Steven V. Ley, Neville J. Anthony, Alan Armstrong et al. · Tetrahedron · 1989 · 93 citations

, , +10

1–5 of 31